Impact of Brokerage Rating on IDEXX Laboratories, Inc.(IDXX)

Many IDEXX Laboratories, Inc.(IDXX) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock. IDEXX Laboratories was Downgraded by Feltl & Co. to Sell on Feb 3, 2017.

Company has reported several Insider transactions to the SEC, on Feb 9, 2017, Brian P Mckeon (Executive VP & CFO) sold 9,924 shares at 141.90 per share price.On Feb 9, 2017, Jonathan W Ayers (Chairman, President & CEO) sold 36,250 shares at 141.87 per share price.On Feb 9, 2017, Daniel M Junius (director) sold 3,000 shares at 141.76 per share price.

IDEXX Laboratories Last issued its quarterly earnings results on Feb 2, 2017. The company reported $0.58 EPS for the quarter, beating the analyst consensus estimate by $ 0.07. Analyst had a consensus of $0.51. The company had revenue of $443.00 million for the quarter, compared to analysts expectations of $436.07 million. The companys revenue was up 10.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.48 EPS.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) has received a short term rating of buy from experts at Zacks with a rank of 2. The stock has been rated an average of 2.5 by 8 Brokerage Firm. 3 Wall Street Firms have rated the stock as a strong buys. 4 Brokerage Firms have advised hold. 1 Analysts have rated it as strong sell.

IDEXX Laboratories, Inc. (NASDAQ:IDXX): 4 analysts have set the short term price target of IDEXX Laboratories, Inc. (NASDAQ:IDXX) at $125.13. The standard deviation of short term price target has been estimated at $26.21, implying that the actual price may fluctuate by this value. The higher and the lower price estimates are $ 150 and $98 respectively.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) witnessed a decline in the market cap on Tuesday as its shares dropped 0.07% or 0.1 points. After the session commenced at $141.11, the stock reached the higher end at $142 while it hit a low of $140.63. With the volume soaring to 682,783 shares, the last trade was called at $141.6. The company has a 52-week high of $143.47. The company has a market cap of $12,696 million and there are 89,658,209 shares in outstanding. The 52-week low of the share price is $67.85.

IDEXX Laboratories, Inc. is a world leader in providing diagnostic, detection, and information products to the animal health industry as well as quality assurance products and services to the food and water industries.


Share this post

Leave a Reply